Head-to-head comparison
Ivy Rx vs Nouri
Two GLP-1 providers, one scorecard. Both are graded on the same six Desk Score dimensions — here is how they stack up, and which one fits you.
Desk Score
Telehealth provider offering tiered compounded semaglutide and tirzepatide programs.
From $175/mo (lowest dose rung) sema · From $275/mo (lowest dose rung) tirz · Verified July 2026
Marked down on: Limited public information on program details
Desk Score
Nouri is a DTC telehealth platform offering compounded semaglutide and tirzepatide bundled with nutrition and movement planning plus clinician messaging — lifestyle support included rather than upsold, on a three-rung price card with a 30-day money-back guarantee.
$175/mo sema · $175/mo (6-month prepay) tirz · Verified August 2026
Marked down on: Tirzepatide's only published figure is a six-month commitment — '$175/month ($1,050 every six months)' — so the same $175/mo headline means 'no commitment' for semaglutide and 'a half-year paid up front' for tirzepatide, on the same page
Ivy Rx takes this head-to-head with the higher Desk Score, 77/100 (C+) against 76/100 (C) for Nouri. Nouri still holds its ground where its strengths line up with yours.
Desk Score, dimension by dimension
Same six measured dimensions for both. The red flag marks the stronger side. See the methodology.
Ivy Rx
77/100
C+
Nouri
76/100
C
Price transparency
State access
Molecule range
Onboarding speed
Support responsiveness
Licensing & trust
The spec sheet
| Field | Ivy Rx | Nouri |
|---|---|---|
| Semaglutide | From $175/molowest dose rung$175/mo (starting dose, compounded) | $175/mo$175/mo month-to-month ($145/mo on the 3-month plan at $435 every three months; $120/mo on the 6-month plan at $720 every six months; compounded) |
| Tirzepatide | From $275/molowest dose rung$275/mo (starting dose, compounded) | $175/mo6-month prepay$175/mo on the 6-month plan ($1,050 every six months; the month-to-month rate is not published, compounded) |
| Coverage | All 50 states | All 50 states |
| Brand-name | Compounded only | Compounded only |
| Oral option | Injectable only | Injectable only |
| Best for | Mainstream telehealth GLP-1 access. | People who want coaching and clinician access included and are willing to commit six months to get the guarantee — semaglutide is the clear product here. |
| Desk Score | 77/100C+ | 76/100C |
The verdict
Desk pick — Ivy RxIvy Rx takes this head-to-head with the higher Desk Score, 77/100 (C+) against 76/100 (C) for Nouri. Nouri still holds its ground where its strengths line up with yours.
Choose Ivy Rx if…
Mainstream telehealth GLP-1 access.
From $175/mo (lowest dose rung) sema · From $275/mo (lowest dose rung) tirz · All 50 states
Choose Nouri if…
People who want coaching and clinician access included and are willing to commit six months to get the guarantee — semaglutide is the clear product here.
$175/mo sema · $175/mo (6-month prepay) tirz · All 50 states
Assume any provider we list may compensate us — we may earn a referral commission at no extra cost to you, and what we write about a provider reads the same either way. Read full breakdowns: Ivy Rx · Nouri.
Also here
CoreAge Rx leads the whole ranking at 94/100
Whichever of these two you lean toward, our #1-rated provider outscores them both. One price at every dose, both molecules, all 50 states. The $99 and $149 figures are 12-month plans paid up front, not a monthly bill.
More head-to-heads
- CoreAge Rx vs Ivy Rx
- CoreAge Rx vs Nouri
- Ivy Rx vs Strut Health
- Nouri vs Trimi
- Ivy Rx vs Trimi
- Elara Health and Wellness vs Nouri
Or see the full comparison hub and the complete ranking.
Pricing and verification reflect each provider's public disclosures at last scoring; the Desk Score is our editorial judgment per the methodology. Prices change — confirm on each provider's own site. Not medical advice; see our disclosure.